These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15731534)

  • 1. Initial and follow-up results of the BiodivYsio phosphorylcholine coated stent for treatment of coronary artery disease.
    Shinozaki N; Yokoi H; Iwabuchi M; Nosaka H; Kadota K; Mitsudo K; Nobuyoshi M
    Circ J; 2005 Mar; 69(3):295-300. PubMed ID: 15731534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with a new biocompatible phosphorylcholine-coated coronary stent.
    Zheng H; Barragan P; Corcos T; Siméoni JB; Favereau X; Roquebert PO; Guérin Y; Sainsous J
    J Invasive Cardiol; 1999 Oct; 11(10):608-14. PubMed ID: 10745442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stenting very small coronary narrowings (< 2 mm) using the biocompatible phosphorylcholine-coated coronary stent.
    Grenadier E; Roguin A; Hertz I; Peled B; Boulos M; Nikolsky E; Amikam S; Kerner A; Cohen S; Beyar R
    Catheter Cardiovasc Interv; 2002 Mar; 55(3):303-8. PubMed ID: 11870932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SV stent study: a prospective, multicentre, angiographic evaluation of the BiodivYsio phosphorylcholine coated small vessel stent in small coronary vessels.
    Bakhai A; Booth J; Delahunty N; Nugara F; Clayton T; McNeill J; Davies SW; Cumberland DC; Stables RH;
    Int J Cardiol; 2005 Jun; 102(1):95-102. PubMed ID: 15939104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian BiodivYsio open registry (BiodivYsio PC-coated stent): study of clinical outcomes of the implant of a PC-coated coronary stent.
    Galli M; Bartorelli A; Bedogni F; DeCesare N; Klugmann S; Maiello L; Miccoli F; Moccetti T; Onofri M; Paolillo V; Pirisi R; Presbitero P; Sganzerla P; Viecca M; Zerboni S; Lanteri G
    J Invasive Cardiol; 2000 Sep; 12(9):452-8. PubMed ID: 10973369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and mid-term results of phosphorylcholine-coated stents in primary coronary stenting for acute myocardial infarction.
    Galli M; Sommariva L; Prati F; Zerboni S; Politi A; Bonatti R; Mameli S; Butti E; Pagano A; Ferrari G
    Catheter Cardiovasc Interv; 2001 Jun; 53(2):182-7. PubMed ID: 11387601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of the phosphorylcholine-coated biodivYsio stent in short de novo coronary lesions: The SOPHOS study.
    Boland JL; Corbeij HA; Van Der Giessen W; Seabra-Gomes R; Suryapranata H; Wijns W; Hanet C; Suttorp MJ; Buller C; Bonnier JJ; Colombo A; Van Birgelen C; Pieper M; Mangioni JA; Londero H; Carere RG; Hamm CW; Bonan R; Bartorelli A; Kyriakides ZS; Chauhan A; Rothman M; Grinfeld L; Oosterwijk C; Serruys PW; Cumberland DC
    Int J Cardiovasc Intervent; 2000 Dec; 3(4):215-225. PubMed ID: 12431346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
    Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".
    Galassi AR; Colombo A; Buchbinder M; Grasso C; Tomasello SD; Ussia GP; Tamburino C
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):976-83. PubMed ID: 17295334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of in-stent restenosis after placement of NIR gold-coated stents in unselected patients.
    Danzi GB; Capuano C; Sesana M; Di Blasi A; Predolini S; Antoniucci D
    Catheter Cardiovasc Interv; 2002 Feb; 55(2):157-62. PubMed ID: 11835639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design.
    Hearn JA; King SB; Douglas JS; Carlin SF; Lembo NJ; Ghazzal ZM
    Circulation; 1993 Nov; 88(5 Pt 1):2086-96. PubMed ID: 8222102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.
    Rensing BJ; Vos J; Smits PC; Foley DP; van den Brand MJ; van der Giessen WJ; de Feijter PJ; Serruys PW
    Eur Heart J; 2001 Nov; 22(22):2125-30. PubMed ID: 11686669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent.
    Abizaid A; Lansky AJ; Fitzgerald PJ; Tanajura LF; Feres F; Staico R; Mattos L; Abizaid A; Chaves A; Centemero M; Sousa AG; Sousa JE; Zaugg MJ; Schwartz LB
    Am J Cardiol; 2007 May; 99(10):1403-8. PubMed ID: 17493469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System.
    Cutlip DE; Garratt KN; Novack V; Barakat M; Meraj P; Maillard L; Erglis A; Jauhar R; Popma JJ; Stoler R; Silber S;
    JACC Cardiovasc Interv; 2017 Jan; 10(2):160-167. PubMed ID: 28104210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Taxus polymer-coated paclitaxel-eluting stents for treatment of in-stent restenosis in real world patients: results of clinical and angiographic follow-up at six months in a single-center registry.
    Lim VY; Buellesfeld L; Gerckens U; Mueller R; Schmidt T; Grube E
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):343-8. PubMed ID: 16897778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
    Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients.
    Di Mario C; Morici N; Godino C; Goktekin O; Tamburino C; Barbagallo R; Antoniucci D; Grube E; Airoldi F; Zoccai GB; Colombo A; Sangiorgi GM
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):416-24. PubMed ID: 17191238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (Abciximab: Reopro) coated stent in patients with coronary artery disease.
    Kim W; Jeong MH; Hong YJ; Lee SH; Park WS; Kim JH; Kim IS; Choi MJ; Ahn YK; Cho JG; Park JC; Cho DL; Kim H; Kang JC
    Korean J Intern Med; 2004 Dec; 19(4):220-9. PubMed ID: 15683110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.
    Lefèvre T; Ormiston J; Guagliumi G; Schultheiss HP; Quilliet L; Reimers B; Brunel P; Wijns W; Buettner HJ; Hartmann F; Veldhof S; Miquel K; Su X; van der Giessen WJ
    J Am Coll Cardiol; 2005 Aug; 46(4):592-8. PubMed ID: 16098421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.
    Aoki J; Nakazawa G; Tanabe K; Hoye A; Yamamoto H; Nakayama T; Onuma Y; Higashikuni Y; Otsuki S; Yagishita A; Yachi S; Nakajima H; Hara K
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):380-6. PubMed ID: 17195199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.